Pinnacle Bancorp’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
Other funds holding CRL
AI
Pinnacle Bancorp's CRL Position: Q2 2026 in Review
Pinnacle Bancorp held its Charles River Laboratories (CRL) position steady in Q2 2026 at 125 shares worth $28.3K. The position accounts for 0.01% of the portfolio, ranked #565.
Pinnacle Bancorp first reported a position in CRL in Q1 2020 and has held it in 20 quarters since. The position peaked at $49K in Q2 2021. 570 funds tracked by Wall St. Rank hold CRL as of Q2 2026.
- Pinnacle Bancorp held 125 shares of Charles River Laboratories worth $28.3K as of Q2 2026.
- Pinnacle Bancorp left its Charles River Laboratories share count unchanged in Q2 2026.
- Charles River Laboratories made up 0.01% of Pinnacle Bancorp's portfolio in Q2 2026, its #565 holding.
- Pinnacle Bancorp first reported a position in Charles River Laboratories in Q1 2020 and has held it in 20 quarters since.
- Pinnacle Bancorp's Charles River Laboratories position peaked at $49K in Q2 2021.
- 570 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.
Based on Pinnacle Bancorp's 13F filing for Q2 2026, filed 28 Jul 2026.